Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Accueil  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Todd E. Simpson
Age : 58
Public asset : 19,810,336 USD
Linked companies : Seagen Inc. - Neoleukin Therapeutics, Inc. - Cascadian Therapeutics Inc (USA)
Summary 
Currently, Todd E. Simpson occupies the position of Chairman for Neoleukin Therapeutics, Inc. and Chief Financial Officer for Seattle Genetics, Inc. Mr. Simpson is also on the board of Cascadian Therapeutics, Inc. and Washington Biotechnology & Biomedical Association.

He previously occupied the position of CFO, VP-Finance & Administration at Vericel Corp., Treasurer of Integra LifeSciences Holdings Corp. and Chief Financial Officer & Vice President for Telios Pharmaceuticals, Inc. (a subsidiary of Integra LifeSciences Holdings Corp.), CFO & VP-Finance & Administration at AmpliPhi Biosciences Corp. and Principal at Ernst & Young LLP.

Mr. Simpson received an undergraduate degree from Oregon State University.


Current positions of Todd E. Simpson 
NameTitle Since
Neoleukin Therapeutics, Inc.
(Biotechnology & Medical Research)
Chairman 2020
Cascadian Therapeutics Inc (USA)
(Biotechnology & Medical Research)
Director 2018
Seagen Inc.
(Biotechnology & Medical Research)
Chief Financial Officer 2005
Washington Biotechnology & Biomedical Association Director 2017


Holdings of Todd E. Simpson 
NameEquities%Valuation
Seagen Inc. (SGEN)
(Biotechnology & Medical Research)
118,7670.068%19,810,336 USD
Neoleukin Therapeutics, Inc. (NLTX)
(Biotechnology & Medical Research)
00.0000%0 USD


Todd E. Simpson: Personal Network 
Most Read News 
11/17WARREN BUFFETT : Buffett's Berkshire bets on Big Pharma, invests in four drugmakers
RE
11/14WARREN BUFFETT : Warren Buffett's Berkshire Is Becoming Its Own Elephant Investment
DJ
11/25THIERRY BRETON : EU's Breton
RE
11/28ELON MUSK : Tesla's Delayed Semi Truck Tests Elon Musk's Ability to Scale Up
DJ
11/15ELON MUSK : Elon Musk says 'most likely' has a moderate case of COVID-19
RE
11/17WILLIAM ACKMAN : As Ackman hunts blockbuster deal, he counts on big backers
RE
11/19MARY BARRA : GM's Barra accelerates 'all out pursuit of global EV leadership'
RE
11/17THEODOR WEIMER : Deutsche Boerse to buy 80% of ISS for $1.8 billion
RE
11/19PETER THIEL : Peter Thiel joins board of antibody therapy developer AbCellera
RE
11/22STEVE WYNN : Top Company News of the Day
DJ
More news


© 2020 People and Ownership :   
Todd E. Simpson : Connections 



Popular Business Leaders 
Jean-paul Agon Bernard Arnault Mary Barra Werner Baumann Jeff Bezos Leon Black Richard Branson Markus Braun Thierry Breton Warren Buffett Bertrand Camus Jean-pierre Clamadieu Tim Cook Jean-charles Decaux Elmar Degenhart Leonardo Del Vecchio Herbert Diess Jack Dorsey Patrick Drahi Nicandro Durante Sergio Ermotti Antoine Frérot Bill Gates Luigi Gubitosi Ralph Hamers David Henry Carl Icahn Arnaud Lagardère Jack Ma Rupert Murdoch Elon Musk Xavier Niel Michael O'leary Bernd Osterloh James Packer Patrick Pouyanné Alessandro Profumo Pedro Pullen Parente Alexandre Ricard Masayoshi Son Carsten Spohr Friede Springer Rupert Stadler Peter Thiel Philippe Varin François Villeroy De Galhau Axel Weber Dieter Zetsche Mark Zuckerberg Luca De Meo
A-Z Business Leaders